These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30890230)

  • 1. Bio-Mimicking Nanoparticles for Targeted Therapy of Malignant Melanoma.
    Zhou X; Yu R; Cao X; Zhang ZR; Deng L
    J Biomed Nanotechnol; 2019 May; 15(5):993-1004. PubMed ID: 30890230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel-Loaded Macrophage Membrane Camouflaged Albumin Nanoparticles for Targeted Cancer Therapy.
    Cao X; Tan T; Zhu D; Yu H; Liu Y; Zhou H; Jin Y; Xia Q
    Int J Nanomedicine; 2020; 15():1915-1928. PubMed ID: 32256068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil-mimicking therapeutic nanoparticles for targeted chemotherapy of pancreatic carcinoma.
    Cao X; Hu Y; Luo S; Wang Y; Gong T; Sun X; Fu Y; Zhang Z
    Acta Pharm Sin B; 2019 May; 9(3):575-589. PubMed ID: 31193785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.
    Parveen S; Sahoo SK
    Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursolic Acid Loaded PLGA Nanoparticles: in vitro and in vivo Evaluation to Explore Tumor Targeting Ability on B16F10 Melanoma Cell Lines.
    Baishya R; Nayak DK; Kumar D; Sinha S; Gupta A; Ganguly S; Debnath MC
    Pharm Res; 2016 Nov; 33(11):2691-703. PubMed ID: 27431865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotin-Conjugated Multilayer Poly [D,L-lactide-co-glycolide]-Lecithin-Polyethylene Glycol Nanoparticles for Targeted Delivery of Doxorubicin.
    Dai Y; Xing H; Song F; Yang Y; Qiu Z; Lu X; Liu Q; Ren S; Chen X; Li N
    J Pharm Sci; 2016 Sep; 105(9):2949-2958. PubMed ID: 27209461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound-guided delivery of microRNA loaded nanoparticles into cancer.
    Wang TY; Choe JW; Pu K; Devulapally R; Bachawal S; Machtaler S; Chowdhury SM; Luong R; Tian L; Khuri-Yakub B; Rao J; Paulmurugan R; Willmann JK
    J Control Release; 2015 Apr; 203():99-108. PubMed ID: 25687306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation-Targeted Delivery of Celastrol via Neutrophil Membrane-Coated Nanoparticles in the Management of Acute Pancreatitis.
    Zhou X; Cao X; Tu H; Zhang ZR; Deng L
    Mol Pharm; 2019 Mar; 16(3):1397-1405. PubMed ID: 30753778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing Engineered Nano-Immunopotentiators for the Stimulation of Dendritic Cells and Inhibition and Prevention of Melanoma.
    Alharthi S; Alavi SZ; Nisa MU; Koohi M; Raza A; Ebrahimi Shahmabadi H; Alavi SE
    Pharm Res; 2024 Jun; 41(6):1163-1181. PubMed ID: 38839718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.
    Chen YC; Hsieh WY; Lee WF; Zeng DT
    J Biomater Appl; 2013 Mar; 27(7):909-22. PubMed ID: 22207601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evaluation of Δ⁹-tetrahidrocannabinol/PLGA nanoparticles for cancer chemotherapy.
    Martín-Banderas L; Muñoz-Rubio I; Prados J; Álvarez-Fuentes J; Calderón-Montaño JM; López-Lázaro M; Arias JL; Leiva MC; Holgado MA; Fernández-Arévalo M
    Int J Pharm; 2015 Jun; 487(1-2):205-12. PubMed ID: 25899283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis.
    Lin TsT; Gao DY; Liu YC; Sung YC; Wan D; Liu JY; Chiang T; Wang L; Chen Y
    J Control Release; 2016 Jan; 221():62-70. PubMed ID: 26551344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor.
    Alam N; Koul M; Mintoo MJ; Khare V; Gupta R; Rawat N; Sharma PR; Singh SK; Mondhe DM; Gupta PN
    Biomed Pharmacother; 2017 Nov; 95():856-864. PubMed ID: 28903181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemocompatibility of folic-acid-conjugated amphiphilic PEG-PLGA copolymer nanoparticles for co-delivery of cisplatin and paclitaxel: treatment effects for non-small-cell lung cancer.
    He Z; Shi Z; Sun W; Ma J; Xia J; Zhang X; Chen W; Huang J
    Tumour Biol; 2016 Jun; 37(6):7809-21. PubMed ID: 26695149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLGA-PEG-RA-based polymeric micelles for tumor targeted delivery of irinotecan.
    Emami J; Maghzi P; Hasanzadeh F; Sadeghi H; Mirian M; Rostami M
    Pharm Dev Technol; 2018 Jan; 23(1):41-54. PubMed ID: 28608760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA-PEG diblock copolymers.
    Beletsi A; Panagi Z; Avgoustakis K
    Int J Pharm; 2005 Jul; 298(1):233-41. PubMed ID: 15936907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery and short-term maternal and fetal safety of vaginally administered PEG-PLGA nanoparticles.
    Irvin-Choy NS; Nelson KM; Gleghorn JP; Day ES
    Drug Deliv Transl Res; 2023 Dec; 13(12):3003-3013. PubMed ID: 37365402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer.
    Vangara KK; Liu JL; Palakurthi S
    Anticancer Res; 2013 Jun; 33(6):2425-34. PubMed ID: 23749891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.